The Economic, Health, and Social Return on Investment in Assistive Technology: A Systematic Review
Main Article Content
Abstract
Objective: To synthesize global evidence on the return on investment (ROI) from assistive technology provision across economic, health, and social domains, demonstrating assistive technology as a strategic investment for achieving Universal Health Coverage and the Sustainable Development Goals.
Methods: We conducted a comprehensive systematic review integrating data from AT scale Global Partnership economic analysis (2020), World Health Organization cost-effectiveness assessments, national program evaluations from Rwanda, Pakistan, and the Philippines, and peer-reviewed literature from PubMed, Web of Science, and Google Scholar (2010-2024). We examined ROI at individual, household, organizational, and national levels, focusing on four priority assistive products (wheelchairs, hearing aids, prostheses, eyeglasses) in low- and middle-income countries. Economic modeling employed quality-adjusted life years, lifetime earnings projections, and macroeconomic multiplier analyses with 5% discount rate.
Findings: Providing sustained access to four priority assistive products for 900 million people in need would yield USD 10 trillion in economic benefits over 55 years, representing 9:1 return on investment against USD 730 billion required investment. Economic gains include USD 4 trillion from improved educational outcomes, USD 4.5 trillion from enhanced employment and productivity, and USD 1.9 trillion from increased caregiver workforce participation. Health benefits equivalent to 1.3 billion quality-adjusted life years would accrue through improved physical and mental health, reduced secondary complications, and enhanced healthcare access. Social returns include community integration, independence, reduced caregiver burden, and gender equality advancement.
Conclusion: Assistive technology represents a strategic investment with demonstrable 9:1 economic ROI and transformative health and social benefits, comparable to WHO Best Buys for noncommunicable disease prevention. Countries must integrate assistive technology within Universal Health Coverage packages and establish sustainable financing mechanisms.
Methods: We conducted a comprehensive systematic review integrating data from AT scale Global Partnership economic analysis (2020), World Health Organization cost-effectiveness assessments, national program evaluations from Rwanda, Pakistan, and the Philippines, and peer-reviewed literature from PubMed, Web of Science, and Google Scholar (2010-2024). We examined ROI at individual, household, organizational, and national levels, focusing on four priority assistive products (wheelchairs, hearing aids, prostheses, eyeglasses) in low- and middle-income countries. Economic modeling employed quality-adjusted life years, lifetime earnings projections, and macroeconomic multiplier analyses with 5% discount rate.
Findings: Providing sustained access to four priority assistive products for 900 million people in need would yield USD 10 trillion in economic benefits over 55 years, representing 9:1 return on investment against USD 730 billion required investment. Economic gains include USD 4 trillion from improved educational outcomes, USD 4.5 trillion from enhanced employment and productivity, and USD 1.9 trillion from increased caregiver workforce participation. Health benefits equivalent to 1.3 billion quality-adjusted life years would accrue through improved physical and mental health, reduced secondary complications, and enhanced healthcare access. Social returns include community integration, independence, reduced caregiver burden, and gender equality advancement.
Conclusion: Assistive technology represents a strategic investment with demonstrable 9:1 economic ROI and transformative health and social benefits, comparable to WHO Best Buys for noncommunicable disease prevention. Countries must integrate assistive technology within Universal Health Coverage packages and establish sustainable financing mechanisms.
Article Details
How to Cite
BADHAL, SUMAN; VASHIST, Arvind; SINGH, Ravinder.
The Economic, Health, and Social Return on Investment in Assistive Technology: A Systematic Review.
Medical Research Archives, [S.l.], v. 14, n. 4, may 2026.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/7404>. Date accessed: 01 may 2026.
Keywords
Assistive Technology, Return of Investment in Assistive Technology, Financial mechanisms in AT, Economic Models in AT
Section
Review Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.